Search filters

List of works by Jessica Cusato

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

scientific article published on 09 May 2020

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

scientific article published on 10 November 2010

A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples

scientific article published on 05 August 2017

ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy

scientific article published on 15 November 2014

Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients.

scientific article published on 8 August 2013

Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients

scientific article published on 28 April 2017

Calcaneal quantitative ultrasound and urine retinol binding protein in HIV-positive antiretroviral-treated patients in Uganda: a pilot study

scientific article published on 28 February 2020

Cannabinoids concentration variability in cannabis olive oil galenic preparations

scientific article

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma

scientific article published on 15 August 2017

Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines.

scientific article published on 6 October 2015

Clinical relevance of deferasirox trough levels in β-thalassemia patients

scientific article

Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B.

scientific article published on 23 November 2017

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients.

scientific article published on 27 March 2017

Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment

scientific article

Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients.

scientific article published on 27 May 2016

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia.

scientific article

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics

scientific article published in July 2012

Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.

scientific article published on 8 August 2013

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS

scientific article published on 07 August 2012

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients

scientific article published on 28 March 2012

Efavirenz pharmacogenetics in a cohort of Italian patients.

scientific article

Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients

scientific article published on 18 September 2014

Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children.

scientific article published on 2 November 2017

Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis B.

scientific article published on 7 July 2016

Estimating ribavirin plasma exposure: genetics or therapeutic drug monitoring?

scientific article

Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study

scientific article

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection

scientific article published on 20 November 2017

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.

scientific article

Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.

scientific article published on 19 September 2016

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

scientific article published on 14 October 2011

High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment

article

High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis

scientific article published on 23 August 2013

Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms.

scientific article published on 12 April 2014

Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study

scientific article published in October 2017

Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.

scientific article

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 21 January 2019

Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness

scientific article published on 28 October 2014

Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane

scientific article published on June 2013

Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment

scientific article published in April 2012

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms

scientific article published on 4 July 2014

Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics.

scientific article published on 14 March 2015

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells

scientific article published on 5 December 2012

Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir.

scientific article published on April 2015

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

scientific article published on 14 January 2013

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.

scientific article published on December 2012

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia.

scientific article published on 28 April 2017

Pharmacogenetics of ribavirin-induced anemia in HCV patients

scientific article published on June 2016

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.

scientific article

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children

scientific article

Precision medicine for HIV: where are we?

scientific article published on 5 December 2017

Prophylactic Drug Monitoring of Itraconazole in an Oncohematological Pediatric Patient Population

scientific article published on 01 October 2012

Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3.

scientific article published on 10 March 2017

Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.

scientific article published in December 2011

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon.

scientific article published on 24 July 2014

Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon.

scientific article

Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.

scientific article published on 4 December 2013

Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C.

scientific article published on June 2017

Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment

scientific article published on 10 June 2015

Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients

scientific article published on 6 November 2014

Role of pharmacogenetics on deferasirox AUC and efficacy.

scientific article published on 4 April 2016

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens

scientific article published on 9 January 2018

Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations

scientific article published on 17 January 2017

Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics

scientific article published on 8 June 2017

SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV

scientific article published on 01 April 2019

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir

scientific article published on 2 September 2013

Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study).

scientific article published on 14 July 2015

Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.

scientific article published on 14 December 2017

Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner.

scientific article published on 20 June 2014

Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment.

scientific article

The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon.

scientific article published on 14 March 2014

The Role of IL28B Genotype in HCV-RNA Baseline Levels

scientific article published on 8 September 2016

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients

scientific article published on 17 January 2019

The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients.

scientific article

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children

scientific article published on 14 August 2017

Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stage.

scientific article published on 7 February 2015

Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study

scientific article published on 15 March 2017

Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors.

scientific article

UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients.

scientific article published on 22 October 2015

UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients

scientific article published on August 2016

UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples

scientific article published on 13 May 2017

Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasma.

scientific article published on December 2013

VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.

scientific article published on April 2015

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV

scientific article published on 25 December 2020

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs

scientific article published on 22 January 2018

Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia

scientific article published on June 2016

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes

scientific article published on 3 October 2014

Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients

scientific article published on 13 February 2018

Paulina is supported by:

About Paulina

Help